Attività Cambiamento Data
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Akebia Therapeutics USD 342.13M 7.53M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amarin USD 634.08M 9.72M 2026-09
ANI Pharmaceuticals USD 1.57B 73.55M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Exelixis USD 2.51B 19.26M 2026-09
Glaxosmithkline GBP 71.7B 8.83B 2026-09
Heron Therapeutics USD 230.45M 21.81M 2026-09
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
Ironwood Pharmaceuticals USD 290.59M 5.46M 2026-09
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Lonza CHF 18.97B 164M 2025-12
Merck USD 132.77B 2.97B 2026-09
Moderna USD 13.47B 2.51B 2026-09
Myriad Genetics USD 638.9M 34.8M 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Pacira USD 34.68B 33.44B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Sanofi EUR 130.29B 1.23B 2026-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
United Therapeutics USD 7.03B 186M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12